Maravai LifeSciences Inc.
MRVI | NASDAQ
$7.17
+$0.20 (+2.87%)
At close: Sep 21, 2026, 4:00 PM ET
$7.30
+$0.13 (+1.81%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 51.44M | 65.84M | 49.87M | 41.63M | 47.4M | 46.85M | 56.41M | 65.2M | 73.4M | 64.18M | 74.14M | 66.87M | 68.91M | 79.03M | 204.71M | 191.26M | 242.73M | 244.29M | 228.44M | 204.81M | 217.78M | 148.21M |
Cost of Revenue | 30.79M | 32.14M | 37.62M | 35.98M | 39.63M | 39.13M | 37.44M | 36.83M | 38.27M | 38.34M | 35.11M | 36.69M | 43.27M | 33.68M | 53.25M | 38.18M | 37.5M | 40.03M | 40.63M | 32.22M | 37.81M | 31.39M |
Gross Profit | 20.65M | 33.7M | 12.24M | 5.66M | 7.77M | 7.73M | 18.96M | 28.37M | 35.13M | 25.84M | 39.03M | 30.18M | 25.64M | 45.35M | 151.46M | 153.09M | 205.24M | 204.26M | 187.81M | 172.59M | 179.96M | 116.82M |
Operating Income | -15.09M | 2.47M | -6.74M | 115.44M | -66.28M | -49.16M | -38.13M | -169.11M | -9.51M | -18.86M | -7.15M | -15.42M | -11.61M | 2.53M | 109.25M | 116.9M | 180.7M | 167.37M | 151.09M | 155.38M | 153.54M | 91.19M |
Interest Income | 1.16M | 1.87M | 2.38M | 15.31M | 3.03M | 3.23M | 6.04M | 7.07M | 7.09M | 7.21M | 7.46M | 7.43M | 6.79M | 6.05M | 2.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -21.8M | -6.53M | -63.01M | -45.15M | -74.13M | -52.69M | -46.5M | -175.64M | -16.93M | -22.41M | 656.19M | -20.56M | -13.36M | -4.52M | 95.88M | 113.76M | 174.99M | 166.84M | 143.82M | 151.02M | 145.88M | 89.17M |
Net Income | -12.42M | -3.73M | -35.68M | -25.56M | -39.59M | -29.95M | -26.15M | -99.04M | -7.59M | -12.08M | -105.96M | -6.46M | -6.54M | -67K | 37.63M | 44.47M | 71.24M | 66.86M | 55.44M | 53.96M | 49.14M | 23.1M |
Selling & General & Admin | 33.82M | 27.34M | 15.19M | 78.14M | 38.58M | 39.56M | 41.24M | 39.09M | 40.56M | 40.89M | 38.48M | 38.86M | 35.38M | 38.67M | 37.2M | 30.8M | 28.06M | 33.2M | 27.55M | 26.51M | 24.5M | 23.47M |
Research & Development | 3.7M | 3.89M | 3.79M | 9.77M | 4.88M | 4.89M | 4.56M | 4.34M | 5.28M | 5.03M | 4.59M | 4.35M | 4.19M | 4.15M | 5.01M | 5.39M | 4.27M | 3.7M | 9.17M | 1.95M | 1.93M | 2.16M |
Other Expenses | -1.75M | n/a | n/a | -197.69M | 30.59M | 12.44M | 11.29M | 154.06M | -1.2M | -1.21M | 3.11M | 2.39M | -2.32M | n/a | n/a | n/a | -7.8M | n/a | n/a | -11.25M | n/a | n/a |
Operating Expenses | 35.77M | 31.23M | 18.98M | -109.79M | 74.05M | 56.89M | 57.09M | 197.49M | 44.64M | 44.71M | 46.18M | 45.6M | 37.26M | 42.82M | 42.21M | 36.18M | 24.54M | 36.9M | 36.73M | 17.21M | 26.43M | 25.63M |
Interest Expense | -16.31M | 5.75M | 6.56M | 6.84M | 6.82M | 6.78M | 11.26M | 13.63M | 11.94M | 10.86M | 15.4M | 11.64M | 7.02M | 11.83M | 10.18M | 3.14M | 4.43M | 2.66M | 4.43M | 7.69M | 7.65M | 7.9M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 66.56M | 63.36M | 56.6M | -73.81M | 113.68M | 96.01M | 94.54M | 234.31M | 82.91M | 83.04M | 81.29M | 82.28M | 80.53M | 76.49M | 95.47M | 74.36M | 62.03M | 76.93M | 77.36M | 49.43M | 64.24M | 57.02M |
Income Tax Expense | -12.03M | -151K | 6K | -92K | -4.29M | 162K | -7K | 311K | -2.44M | 271K | 766.17M | -5.46M | -1.42M | -3.18M | 8.45M | 14.11M | 18.27M | 19.98M | 17.58M | 18.84M | 11.39M | 13.71M |
Shares Outstanding (Basic) | 147.22M | 146.43M | 145.07M | 144.68M | 144.24M | 143.43M | 141.81M | 141.56M | 135.84M | 132.33M | 132.14M | 131.93M | 131.86M | 131.74M | 131.63M | 131.54M | 131.5M | 131.5M | 131.46M | 118.43M | 112.2M | 96.65M |
Shares Outstanding (Diluted) | 147.22M | 146.43M | 145.07M | 144.68M | 144.24M | 143.43M | 139.73M | 141.56M | 135.84M | 132.33M | 132.14M | 131.93M | 131.86M | 131.74M | 131.65M | 131.65M | 121.97M | 121.97M | 121.97M | 121.97M | 112.28M | 96.67M |
EPS (Basic) | -0.08 | -0.03 | -0.25 | -0.18 | -0.27 | -0.21 | -0.18 | -0.70 | -0.06 | -0.09 | -0.80 | -0.05 | -0.05 | -0.01 | 0.66 | 0.76 | 1.19 | 1.12 | 0.42 | 0.46 | 0.44 | 0.24 |
EPS (Diluted) | -0.08 | -0.03 | -0.25 | -0.18 | -0.27 | -0.21 | -0.18 | -0.70 | -0.06 | -0.09 | -0.80 | -0.05 | -0.05 | -0.01 | 0.66 | 0.76 | 1.28 | 1.20 | 0.42 | 0.44 | 0.44 | 0.24 |
EBITDA | -15.09M | 12.2M | -41.72M | -22.46M | -51.92M | -31M | -20.71M | -147.97M | 9.56M | 2.21M | 684.57M | 4.17M | 5.46M | 18.22M | 116.09M | 126.81M | 188.34M | 178.76M | 151.7M | 166.71M | 163.7M | 103.38M |
EBIT | n/a | -779K | -56.45M | -38.31M | -67.31M | -45.91M | -35.24M | -162.01M | -4.99M | -11.55M | 671.59M | -8.93M | -6.34M | 7.31M | 106.06M | 116.9M | 179.43M | 169.51M | 148.26M | 158.7M | 153.53M | 97.08M |
Depreciation & Amortization | -12.98M | 12.98M | 14.73M | 15.84M | 15.39M | 14.91M | 14.53M | 14.04M | 14.55M | 13.75M | 12.98M | 13.1M | 11.8M | 10.91M | 10.03M | 9.91M | 8.91M | 9.26M | 3.44M | 8M | 10.17M | 6.3M |
Add to Watchlist
Select watchlists to add or remove MRVI